GlassScriptPhysician profile
Vijay B Dave
NPI 1316933443
$11,039.36
in general payments reported to CMS, 2019-2025
33 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,903 · 2020: $1,198 · 2021: $2,016 · 2022: $1,689 · 2023: $950 · 2024: $958 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,416.13 | 2019-2023 | Farxiga |
| Novartis Pharmaceuticals Corporation | $1,956.28 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,062.19 | 2019-2023 | Xarelto |
| Amgen INC. | $882.10 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $548.27 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $540.75 | 2019-2024 | Lifevest |
| Esperion Therapeutics, INC. | $464.32 | 2020-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $334.63 | 2021-2022 | |
| Boston Scientific Corporation | $296.42 | 2022-2024 | Watchman Flx |
| Chiesi USA, INC. | $268.16 | 2020-2022 | |
| Inspire Medical Systems, INC. | $216.81 | 2023-2024 | Inspire |
| Alnylam Pharmaceuticals INC. | $191.69 | 2019-2021 | |
| Abbott Laboratories | $191.06 | 2019-2024 | Perclose Prostyle, Femostop |
| Ekos Corporation | $168.33 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $155.36 | 2020-2025 | Opsumit, Opsynvi, Uptravi |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $130.76 | 2023 | Monarch Platform |
| Lexicon Pharmaceuticals, INC. | $122.80 | 2024 | Inpefa |
| Novo Nordisk INC | $120.65 | 2024 | |
| Edwards Lifesciences Corporation | $106.64 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $101.60 | 2020-2023 | |
| Zoll Circulation INC | $100.00 | 2023 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.06 | 2019 | |
| Amarin Pharma, INC. | $99.05 | 2019-2022 | |
| Lundbeck LLC | $92.93 | 2019-2020 | |
| Endologix LLC | $92.07 | 2022 | |
| Biosense Webster, INC. | $87.10 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $47.08 | 2019-2021 | |
| Angiodynamics, INC. | $45.50 | 2022-2023 | Alphavac |
| Sanofi-Aventis U.S. LLC | $30.05 | 2019 | |
| Cardiovascular Systems INC. | $26.42 | 2019 | |
| Amryt Pharma Holdings LTD | $16.12 | 2021 | |
| Allergan, INC. | $15.97 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Dave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.